CAS 371935-79-4

Fórmula: C19H17ClN4O3

InChI: InChI=1S/C19H16N4O3.ClH/c24-13-4-1-3-12(11-13)17-21-15-14-5-2-6-20-19(14)26-16(15)18(22-17)23-7-9-25-10-8-23;/h1-6,11,24H,7-10H2;1H

Clave InChI: XSQMYBFFYPTMFE-UHFFFAOYSA-N

SMILES: C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O.Cl

PI-103 Hydrochloride

CAS: 371935-79-4

PI-103 Hydrochloride

Fórmula: C₁₉H₁₇ClN₄O₃

Pureza: ≥95%

Peso molecular: 384.82

Ref: 54-BUP23140

3-(4-Morpholinopyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol hydrochloride

CAS: 371935-79-4

Fórmula: C₁₉H₁₇ClN₄O₃

Pureza: 97%

Forma y color: Solid

Peso molecular: 384.8163

Ref: IN-DA00C6H9

PI-103 Hydrochloride

CAS: 371935-79-4

PI-103 Hydrochloride is a dual PI3K/Akt and mTOR inhibitor exhibiting nM-level inhibition of p110α, p110β, p110δ, p110γ, DNA-PK, mTORC1, and mTORC2.

Fórmula: C₁₉H₁₇ClN₄O₃

Pureza: 97.07%

Forma y color: White Solid

Peso molecular: 384.82

Ref: TM-T6143L

3-(4-Morpholinopyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol hydrochloride

CAS: 371935-79-4

Fórmula: C₁₉H₁₇ClN₄O₃

Pureza: ≥97%

Peso molecular: 384.82

Ref: 10-F464453

PI 103 hydrochloride

CAS: 371935-79-4

PI 103 hydrochloride is a pharmacological compound, specifically a dual inhibitor, which is synthetically derived. It acts by inhibiting both the phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) pathways. This compound disrupts signaling pathways critical for cell growth and survival, making it a valuable tool in cancer research. By targeting these pathways, PI 103 hydrochloride is used to investigate cellular processes and mechanisms underlying tumor growth and proliferation. Researchers employ this compound to study the effects of pathway inhibition on cancer cells, potentially leading to the development of novel therapeutic strategies. This makes PI 103 hydrochloride a significant component in the exploration of targeted cancer therapies and advanced studies in cellular biology.

Fórmula: C₁₉H₁₆N₄O₃·HCl

Pureza: Min. 95%

Peso molecular: 384.82 g/mol

Ref: 3D-WPA93579